Supernus Pharmaceuticals | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Abbott USD 6.53B 1.08B 2025-03
ANI Pharmaceuticals USD 149.8M 4.94M 2025-03
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 89.82M 37.85M 2025-03
Eisai JPY 265.56B 25.7B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Indivior 372M 53M 2025-03
Pacira USD 283.61M 6.84M 2025-03
Perrigo USD 409.9M 148.9M 2025-03
Pfizer USD 1.43B 387M 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
United Therapeutics USD 1.9B 202.7M 2025-03
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12



Supernus Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.